Skip to main content

Want a detailed portfolio tracker?

Evaxion Biotech A/S (EVAX) P/E (2021 - 2026)

Evaxion Biotech A/S (EVAX) P/E from Feb 5, 2021 to Jul 21, 2026. The TTM Evaxion Biotech A/S (EVAX) P/E is -6.94. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Evaxion Biotech A/S (EVAX)

YearP/EChange
2026-6.94+34.38%
2025-5.16+70.66%
2024-3.03-97.68%
2023-130.37-61.37%
2022-337.47-59.84%
2021-840.35N/A

Comparison Evaxion Biotech A/S (EVAX) P/E with competitors

Evaxion Biotech A/S (EVAX) P/E is -6.94.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.08%
FGENFibroGen Inc0.24-103.46%
CHRSCoherus Biosciences Inc0.85-112.23%
FBIOFortress Biotech Inc0.95-113.68%
ORMPOramed Pharmaceuticals Inc1.50-121.66%
AGENAgenus Inc3.01-143.37%
INVAInnoviva Inc3.15-145.45%
VXRTVaxart Inc3.55-151.16%
CRMDCorMedix Inc3.63-152.29%
CVACCureVac N.V.4.45-164.07%
GLPGGalapagos NV4.86-170.02%
SRPTSarepta Therapeutics Inc4.88-170.36%
ABEOAbeona Therapeutics Inc5.39-177.64%
ABUSArbutus Biopharma Corp5.60-180.64%
ZVRAZevra Therapeutics Inc5.89-184.84%
SPROSpero Therapeutics Inc6.23-189.76%
CGENCompugen Ltd6.31-190.99%
RIGLRigel Pharmaceuticals6.87-199.04%
SLXNSilexion Therapeutics Corp7.30-205.15%
OMEROmeros Corporation9.26-233.43%
AUPHAurinia Pharmaceuticals Inc9.58-238.13%
PLXProtalix BioTherapeutics Inc10.89-256.95%
ACADAcadia Pharmaceuticals Inc11.73-269.02%
TBPHTheravance Biopharma Inc12.26-276.71%
ADMAAdma Biologics Inc12.42-278.96%
HRMYHarmony Biosciences Holdings Inc13.82-299.17%
SABSSAB Biotherapeutics Inc14.14-303.72%
NAGENiagen Bioscience Inc14.82-313.55%
INCYIncyte Corp15.82-328.03%
REGNRegeneron Pharmaceuticals Inc15.86-328.52%
PBYIPuma Biotechnology Inc17.32-349.54%
CPRXCatalyst Pharmaceuticals Inc17.44-351.33%
EXELExelixis Inc17.54-352.75%
TGTXTG Therapeutics Inc18.97-373.33%
MDXGMimedx Group Inc20.55-396.19%
XOMAXOMA Royalty Corp22.87-429.67%
ARGXArgen X SE24.30-450.18%
CTMXCytomX Therapeutics Inc24.82-457.72%
XOMAOXOMA Royalty Corp25.34-465.26%
HALOHalozyme Therapeutics Inc25.62-469.28%
XOMAPXOMA Royalty Corp25.67-469.95%
VRTXVertex Pharmaceuticals Inc27.99-503.46%
RPRXRoyalty Pharma plc - Class A28.69-513.44%
SLNOSoleno Therapeutics Inc29.02-518.16%
ASNDAscendis Pharma A/S30.09-533.59%
LGNDLigand Pharmaceuticals Inc - Class B37.91-646.38%
APLSApellis Pharmaceuticals Inc39.02-662.37%
BMRNBiomarin Pharmaceutical Inc42.21-708.35%
KRYSKrystal Biotech Inc45.34-753.48%
ONCBeiGene Ltd69.54-1102.20%
PHARPharming Group N.V.75.03-1181.26%
TECHBio-Techne Corp101.96-1569.41%
VCELVericel Corp109.92-1684.17%
ALNYAlnylam Pharmaceuticals Inc117.96-1800.09%
GMABGenmab140.29-2121.85%
TLXTelix Pharmaceuticals Ltd162.15-2436.92%
CORTCorcept Therapeutics Inc212.86-3167.67%